496 Canine Sports Medicine and Rehabilitation
Webliography
European Medicines Agency. 2005. Document refer-
ence: Doc.Ref.:EMEA/590296/2008. http://www.
ema.europa.eu/docs/en_GB/documentlibrary/
EPAR‐_Scientific_Discussion/human/000572/
WC500036776.pdf.
International Veterinary Academy of Pain
Management (IVAPM). http://iavpm.org.
Therapeutic Goods Administration. 2011. Australian
Public Assessment Report of Tapentadol. Table 1:
Minimal efficacious doses in various animal
pain models, p9. https://www.tga.gov.au/sites/
default/files/auspar‐palexia‐sr.pdf.
Young, K. 2008. FDA Center for Drug Evaluation and
Research: Tapentadol, Application No. 22‐304.
Section 3.3.5 Metabolism, p60‐62. https://www.
accessdata.fda.gov/drugsatfda_docs/nda/
2008/022304s000_MedR_P1.pdf.
All websites accessed November 2017.
References
Abbo, L. A., Ko, J. C., Maxwell, L. K., Galinsky, R. E.,
Moody, D. E., Johnson, B. M. & Fang, W. B. 2008.
Pharmacokinetics of buprenorphine following
intravenous and oral transmucosal administration
in dogs. Vet Ther, 9, 83–93.
Altman, R. D., Dean, D. D., Muniz, O. E. & Howell, D.
S. 1989. Therapeutic treatment of canine osteoar-
thritis with glycosaminoglycan polysulfuric acid
ester. Arthritis Rheum, 32, 1300–1307.
AMERICAN PAIN SOCIETY. 2002. Guideline for the
Management of Pain in Osteoarthritis, Rheumatoid
Arthritis, and Juvenile Chronic Arthritis, 2nd edn.
Glenview, IL: APS.
Anand, K. J. S. & Hickey, P. R. 1992. Halothane–mor-
phine compared with high‐dose sufentanil for
anesthesia and postoperative analgesia in neona-
tal cardiac surgery. New England Journal of Medicine,
326, 1–9.
Backonja, M. & Glanzman, R. L. 2003. Gabapentin
dosing for neuropathic pain: evidence from rand-
omized, placebo‐controlled clinical trials. Clin
Ther, 25, 81–104.
Baek, I. H., Lee, B. Y., Kang, W. & Kwon, K. I. 2013.
Pharmacokinetic analysis of two different doses of
duloxetine following oral administration in dogs.
Drug Res (Stuttg), 63(8), 404–408.
Barkin, R., Iusco, M. & Barkin, S. 2006. Opioids used
in primary care for the management of pain: a
pharmacologic, pharmacotherapeutic, and phar-
macodynamics overview. In: Boswell, M. V., Cole,
B. E. & Weiner, R. S. (eds), Weiner’s Pain Management:
A Practical Guide for Clinicians, 7th edn. Boca Raton,
FL: CRC Press/Taylor & Francis, p. 791.
Barnhart, M. D., Hubbell, J. A., Muir, W. W., Sams, R.
A. & Bednarski, R. M. 2000. Pharmacokinetics,
pharmacodynamics, and analgesic effects of mor-
phine after rectal, intramuscular, and intravenous
administration in dogs. Am J Vet Res, 61, 24–28.
Bazin, J. E., Massoni, C., Bruelle, P., Fenies, V.,
Groslier, D. & Schoeffler, P. 1997. The addition of
opioids to local anaesthetics in brachial plexus
block: the comparative effects of morphine,
buprenorphine and sufentanil. Anaesthesia, 52,
858–862.
Belshaw, Z., Asher, L. & Dean, R. S. 2016. The atti-
tudes of owners and veterinary professionals in
the United Kingdom to the risk of adverse events
associated with using non‐steroidal anti‐inflam-
matory drugs (NSAIDs) to treat dogs with osteo-
arthritis. Prev Vet Med, 131, 121–126.
Benedetti, F., Amanzio, M., Vighetti, S. & Asteggiano,
G. 2006. The biochemical and neuroendocrine
bases of the hyperalgesic nocebo effect. J Neurosci,
26, 12014–12022.
Benitez, M. E., Roush, J. K., Kukanich, B. &
McMurphy, R. 2015a. Pharmacokinetics of hydroc-
odone and tramadol administered for control of
postoperative pain in dogs following tibial pla-
teau leveling osteotomy. Am J Vet Res, 76(9),
763–770.
Benitez, M. E., Roush, J. K., McMurphy, R., Kukanich,
B. & Legallet, C. 2015b. Clinical efficacy of hydroc-
odone‐acetaminophen and tramadol for control of
postoperative pain in dogs following tibial plateau
leveling osteotomy. Am J Vet Res, 76(9), 755–762.
Boileau, C., Martel‐Pelletier, J., Brunet, J., Tardif, G.,
Schrier, D., Flory, C., et al. 2005. Oral treatment with
PD‐0200347, an alpha2delta ligand, reduces the
development of experimental osteoarthritis by
inhibiting metalloproteinases and inducible nitric
oxide synthase gene expression and synthesis in car-
tilage chondrocytes. Arthritis Rheum, 52, 488–500.
Boscan, P., Pypendop, B. H., Solano, A. M. & Ilkiw, J.
E. 2005. Cardiovascular and respiratory effects of
ketamine infusions in isoflurane‐anesthetized
dogs before and during noxious stimulation. Am J
Vet Res, 66, 2122–2129.
Boscan, P., Monnet, E., Mama, K., Twedt, D. C.,
Congdon, J. & Steffey, E. P. 2011. Effect of maropi-
tant, a neurokinin 1 receptor antagonist, on anes-
thetic requirements during noxious visceral
stimulation of the ovary in dogs. Am J Vet Res, 72,
1576–1579.
Bostrom, I. M., Nyman, G. C., Lord, P. E., Haggstrom,
J., Jones, B. E. & Bohlin, H. P. 2002. Effects of car-
profen on renal function and results of serum bio-
chemical and hematologic analyses in anesthetized
dogs that had low blood pressure during anesthe-
sia. Am J Vet Res, 63, 712–721.
Brondani, J. T., Luna, L. S. P., Beier, S. L., Minto, B.
W. & Padovani, C. R. 2009. Analgesic efficacy of